Year None202420232022202120202019201820172016 06-12-2024 Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 06-06-2024 Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™ 05-21-2024 Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International Conference 05-14-2024 Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis 05-07-2024 Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™ 05-06-2024 Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results 05-01-2024 Pliant Therapeutics to Participate in Upcoming Investor Events 04-02-2024 Pliant Therapeutics to Participate in Upcoming Investor Events 03-27-2024 Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference 03-12-2024 Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Next page next › Last page last »